| Bill | HR 7384 |
|---|---|
| Type of Legislation | House Bill |
| Congress | 118 |
| Status | Archived — 118th Congress concluded |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Creating Hope Reauthorization Act of 2024
This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
Bill Title
Creating Hope Reauthorization Act of 2024
Linked Goals
Steps
Steps taken on this bill were not available from Congress.gov.
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.